NCT05264025View on ClinicalTrials.gov

Fexofenadine in Patients With Active Rheumatoid Arthritis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Fexofenadine

tablet

DRUG

Placebo

tablet

Trial Locations (2)

Unknown

RECRUITING

Beni-Suef Hospital, Banī Suwayf

RECRUITING

Faculty of Medicine - Beni Suef Hospital, Banī Suwayf

All Listed Sponsors
lead

October 6 University

OTHER